See the latest news and media coverage for Neion Bio. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biomanufacturing platform company
neionbio.comLast updated
In short: Neion Bio emerged from stealth and secured $23 million in Series A funding to advance its avian-based biologics manufacturing platform.
The company endorses bipartisan efforts to strengthen domestic manufacturing but argues true resilience requires simpler, distributed biotech production approaches.
Ming Li highlighted cost-effective, resilient production as key for medicine accessibility. The company advocates leapfrog technologies beyond traditional methods to achieve health abundance.
Sven Bocklandt discussed the world's most efficient drug factories in the Belgian publication. The post hints at a chicken, genome, and pharmaceutical theme.
The presentation covers the company's vision, scheduled for Tuesday May 5th at 9:30am.
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, today announced the close of an...
A prepared egg awaits the introduction of engineered primordial germ cells carrying a targeted transgene. Once incorporated into the germline, the modification enables future generations...
Most of the world's top-selling drugs, including the leading cancer immunotherapy Keytruda, are protein-based. It's a well-known fact in academia that over 70% of these...
It may contain inaccuracies due to the limitations of machine translation. American biotech startup 'Neion Bio' is focused on commercializing a platform to produce pharmaceuticals...
Track Neion Bio and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Neion Bio and other trending companies.